HLA-DRB1 and myeloid sarcoma: In addition, a longitudinal review study which include 72 published articles (1993-2004) was completed by Human Genome Epidemiology has showed that MHC class II region, notably individuals with HLA-DRB1 * 15:01 allele, was in high risk to MS [9,10].